Scott’s Sales growth of 6% was in line with our estimate, but EPS of $2.17 handily surpassed our estimate of $1.94 in light of positive progress on gross margin as well as below-the-line items. Relative to our estimate, a higher gross margin rate and the benefit of lower interest expense and a favorable tax rate contributed $0.11 and $0.09 to earnings per share, respectively.
Despite the solid earnings beat, management reaffirmed—rather than raised—its full-year earnings guidance, calling for EPS in the range of $3.05 to $3.20. While we perceive this approach can be attributed in part to conservatism, it also reflects the reality that the most significant point-of-sale months for the company lie ahead. Moreover, given the slow start to the season, point-of-sale growth in the range of 5% to 7% will likely be necessary for the company to achieve its full-year sales growth guidance of 2% to 3%.
Even so, we believe positive progress on gross margin and contributions from below-the-line items create earnings flexibility and, in turn, upside earnings potential. We increased our 2014 and 2015 EPS estimates by $0.05 each, to $3.20 (up 15%) and $3.55 (up 11%), respectively. Separately, given an alreadystrong and improving financial position, Scotts is closer to returning more cash to shareholders, and management implied that a special dividend could be in the offing later this year. We continue to like the story given the strength of Scotts’ brand portfolio, its distinctive operating capabilities, the company’s improving profitability metrics, and its strong financial position and free cash flow generation.
Key Highlights (Details Below) Second-quarter EPS above on gross margin and below-the-line items Pricing, cost, and productivity create earnings flexibility Earnings estimates increased slightly Reported. Scotts reported fiscal second-quarter (March) EPS of $2.17, compared with our estimate of $1.94, consensus of $1.98, and $1.60 a year ago. Reported sales increased by 6%, to $1.08 billion, versus our estimate of $1.07 billion and consensus of $1.09 billion; gross margin was 40.1%, up 290 basis points and above our forecast of 39.2%; and SG&A expense (as a percentage of sales) was 19.6%, down 70 basis points and 50 basis points below our estimate. Outlook. Despite the solid earnings beat, management reaffirmed—rather than raised— its full-year earnings guidance, calling for EPS in the range of $3.05 to $3.20.
While we believe this approach can be attributed in part to conservatism, it also reflects the reality that the most significant point-of-sale months for the company lie ahead. Moreover, given the slow start to the season, point-of-sale growth in the range of 5% to 7% will likely be necessary for the company to achieve its full-year sales growth guidance of 2% to 3%. As a result, we only raised our 2014 and 2015 EPS estimates by $0.05 each, to $3.20 (up 15%) and $3.55 (up 11%), respectively.
Pingback: cialis no prescription
Pingback: albuterol for sale
Pingback: generic viagra
Pingback: generic chloroquine
Pingback: purchase cialis online
Pingback: is there generic for lumigan
Pingback: cialis 20 mg price
Pingback: cialis for sale
Pingback: Viagra 150mg online pharmacy
Pingback: order Cialis 10 mg
Pingback: where to buy Cialis 40 mg
Pingback: sildenafil 200mg over the counter
Pingback: levitra 60 mg usa
Pingback: cheapest lasix 100 mg
Pingback: where can i buy amaryl 4mg
Pingback: cheapest antabuse 500 mg
Pingback: arimidex 1 mg uk
Pingback: tamoxifen 10 mg canada
Pingback: order atarax 10 mg
Pingback: where can i buy augmentin 500/125 mg
Pingback: avapro 300mg generic
Pingback: avodart 0,5mg pills
Pingback: bactrim 800/160 mg for sale
Pingback: Biaxin 250mg canada
Pingback: Premarin 0,625mg over the counter
Pingback: buspar 5mg price
Pingback: cardizem pills
Pingback: casodex 50mg tablets
Pingback: bad credit loans online no credit check
Pingback: essay writer online
Pingback: essay writing service canada
Pingback: cleocin 300mg without a doctor prescription
Pingback: how to purchase lamisil
Pingback: lopid for sale
Pingback: proair inhaler over the counter
Pingback: zestril generic
Pingback: zithromax 100mg online pharmacy
Pingback: clonidine without a doctor prescription
Pingback: celecoxib 100 mg prices
Pingback: bisacodyl united states
Pingback: where to buy loperamide
Pingback: azathioprine united kingdom
Pingback: where to buy digoxinmg
Pingback: order levothyroxine mcg
Pingback: metoprolol pharmacy
Pingback: upg168
Pingback: ซอฟต์แวร์บริหารงานบริการทำความสะอาด
Pingback: Avawin สล็อตเว็บตรงจากต่างประเทศ
Pingback: หาฤกษ์คลอด
Pingback: ufazeed